• Reliable c-Myc-Max Dimerization Inhibition: Laboratory Sc...

  2026-01-30

  This article presents actionable, scenario-driven guidance for using 10058-F4 (SKU A1169) as a robust, cell-permeable c-Myc-Max dimerization inhibitor in apoptosis, cell viability, and cancer biology assays. Drawing on literature and experimental benchmarks, it demonstrates how APExBIO’s 10058-F4 enhances reproducibility and data confidence in acute myeloid leukemia and prostate cancer models.

• Cycloheximide (SKU A8244): Reliable Protein Biosynthesis ...

  2026-01-29

  Cycloheximide (SKU A8244) offers bench scientists a highly characterized, reproducible protein biosynthesis inhibitor for apoptosis assays, protein turnover studies, and translational control research. This article presents scenario-driven guidance addressing real laboratory challenges, highlighting how APExBIO’s Cycloheximide enhances data reliability, workflow sensitivity, and experimental clarity for demanding cell-based assays.

• CB-5083: Unlocking p97 Inhibition for DNA Repair and Sene...

  2026-01-29

  Explore how CB-5083, a selective p97 inhibitor, enables novel insight into DNA repair mechanisms, genome stability, and cancer cell apoptosis. This article uniquely links protein homeostasis disruption to longevity research, setting it apart from standard oncology-focused reviews.

• Ceapin-A7: Precision ATF6α Pathway Inhibition in ER Stres...

  2026-01-28

  Ceapin-A7 empowers researchers with selective and reproducible ATF6α pathway inhibition, revolutionizing endoplasmic reticulum stress studies and disease modeling. With its robust workflow compatibility and actionable troubleshooting strategies, this APExBIO chemical probe sets a new standard for unfolded protein response modulation in protein misfolding disease models.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Optimizing Fl...

  2026-01-28

  The One-step TUNEL Cy5 Apoptosis Detection Kit delivers precise, reproducible fluorescent detection of apoptosis-associated DNA fragmentation in tissue sections and cultured cells. Unlike traditional assays, its streamlined protocol and Cy5 labeling empower advanced research in cancer, neurodegeneration, and drug resistance. Discover how APExBIO’s K1135 kit transforms experimental workflows for robust, quantitative assessment of programmed cell death.

• Z-DEVD-FMK: Irreversible Caspase-3 Inhibitor for Apoptosi...

  2026-01-27

  Z-DEVD-FMK is a cell-permeable, irreversible caspase-3 inhibitor used in apoptosis assays and neurodegenerative disease models. This article details its dual caspase-calpain inhibition, experimental benchmarks, and integration into cancer and neuroprotection workflows. APExBIO's A1920 formulation offers robust reproducibility for dissecting caspase signaling pathways.

• Fucoidan: Advanced Mechanisms and Translational Insights ...

  2026-01-27

  Explore the multifaceted bioactivity of Fucoidan, a sulfated polysaccharide from brown seaweed, with a unique focus on apoptosis induction and immune modulation in cancer and neuroprotection. This in-depth analysis connects molecular mechanisms with translational opportunities, offering new perspectives beyond standard protocols.

• Irinotecan: Applied Workflows for Colorectal Cancer Research

  2026-01-26

  Irinotecan (CPT-11) empowers cancer biology labs with reproducible, mechanism-focused workflows that drive breakthroughs in DNA damage and apoptosis research. This guide details how APExBIO’s Irinotecan stands out in colorectal cancer model systems, offering actionable protocols, troubleshooting strategies, and optimized use-cases for both classic and next-generation assays.

• MLN8237 (Alisertib): Unraveling Aurora A Kinase Inhibitio...

  2026-01-26

  Explore the advanced molecular mechanisms and experimental strategies of MLN8237 (Alisertib), a selective Aurora A kinase inhibitor for cancer research. This article delivers a unique, in-depth analysis of its role in apoptosis induction and tumor growth inhibition, with insights beyond standard workflows.

• Fulvestrant (ICI 182,780): Distinct Mechanisms & Research...

  2026-01-25

  Discover the multifaceted role of Fulvestrant (ICI 182,780) as an estrogen receptor antagonist in ER-positive breast cancer treatment. This in-depth analysis explores emerging mechanisms—including immune modulation, ER stress interplay, and advanced sensitization strategies—offering novel insights beyond standard applications.

• Dissecting Lysosomal Protease Pathways in Cell Death: Str...

  2026-01-24

  This article delivers a thought-leadership perspective on the mechanistic role of cathepsin B in regulated cell death, highlighting recent breakthroughs in necroptosis research. It provides translational researchers with actionable guidance on leveraging CA-074 Me—a highly selective, cell-permeable cathepsin B inhibitor from APExBIO—to advance apoptosis, necroptosis, and inflammation models. By integrating fresh evidence from the latest literature and scenario-driven workflow recommendations, the article transcends standard product resources, offering a comprehensive roadmap for experimental innovation and therapeutic exploration.

• DMXAA (Vadimezan): Integrating Vascular Disruption and En...

  2026-01-23

  Explore how DMXAA (Vadimezan, AS-1404) redefines vascular disruption in cancer biology research by linking DT-diaphorase inhibition, VEGFR2 blockade, and the latest insights on endothelial immunity. This in-depth article uniquely integrates advanced mechanism, application, and translational impact.

• MRT68921: Precision ULK1/2 Inhibition for Autophagy Research

  2026-01-23

  MRT68921 empowers researchers to dissect autophagy signaling with unprecedented specificity by targeting both ULK1 and ULK2 kinases. Its unique potency and selectivity make it the ideal tool for advanced lipid metabolism studies, autophagy inhibition workflows, and troubleshooting complex cellular models. APExBIO provides researchers with the reliability and technical support needed for reproducible, high-impact results.

• Clodronate Liposomes: Redefining Macrophage Depletion for...

  2026-01-22

  Explore how Clodronate Liposomes enable innovative, selective in vivo macrophage depletion and immune cell modulation. Delve into mechanisms, emerging applications in tumor immunology, and advanced strategies for tackling immunotherapy resistance.

• Necrostatin-1: Selective RIP1 Kinase Inhibitor for Necrop...

  2026-01-22

  Necrostatin-1 (Nec-1) is a potent, selective allosteric inhibitor of RIP1 kinase, widely used in necroptosis assays and acute kidney injury research. Its validated nanomolar-range efficacy and reproducibility have cemented its role as a gold standard for dissecting RIP1 kinase signaling pathways in inflammatory and degenerative disease models.

462 records 24/31 page Previous Next First page 上5页 2122232425 下5页 Last page